Related Experiment Videos
Antiproliferative effect of neomycin in glioma cells
Pedro Cuevas1, Diana Diaz-González, Manuel Dujovny
1Departamento de Investigación, Hospital Universitario Ramón y Cajal, Universidad de Alcalá de Henares, Madrid, Spain. pedro.cuevas@hrc.es
Abstract:
The angiogenic growth factor (AGF) family of signaling molecules has been implicated in normal development and in physiological process as well as in human malignancy. Since blockage of nuclear translocation of AGF in endothelial cells with neomycin resulted in inhibition of the growth factor capacity to induce angiogenesis, we treated glioma cells with neomycin and assessed its effects on cell proliferation. Administration of 10mM neomycin during two days resulted in a 56% inhibition of glioma cells proliferation. This result may provide the basis for the development of a novel adjuvant therapeutic strategy forgliomas.
Insights
Neomycin, an antibiotic, significantly inhibited glioma cell proliferation by 56% in a two-day study. This finding suggests neomycin could be a potential adjuvant therapy for gliomas by blocking angiogenic growth factor (AGF) activity.
Area of Science:
- Molecular Biology
- Oncology
- Pharmacology
Background:
- Angiogenic growth factor (AGF) family signaling molecules are involved in development, physiological processes, and human cancers.
- Inhibition of AGF nuclear translocation in endothelial cells with neomycin reduces angiogenesis.
- Gliomas are a type of brain tumor characterized by abnormal cell proliferation.
Purpose of the Study:
- To investigate the effect of neomycin on glioma cell proliferation.
- To explore the potential of neomycin as an adjuvant therapeutic agent for gliomas.
Main Methods:
- Glioma cells were treated with 10mM neomycin.
- Cell proliferation was assessed after two days of treatment.
Main Results:
- Neomycin administration resulted in a 56% inhibition of glioma cell proliferation.
- The study demonstrated a direct impact of neomycin on glioma growth.
Conclusions:
- Neomycin effectively inhibits glioma cell proliferation.
- These findings support the development of neomycin as a novel adjuvant therapeutic strategy for gliomas.